Aplagon raised €7M in a funding round led by Fåhraeus Startup and Growth AB and the European Innovation Council Fund to support the clinical development of APAC for thrombo-inflammatory diseases.
Amount Raised
€7
Round Type
Pre-Seed
HelsinkiBiotechnologyHealth CareTherapeuticsInvestors
Description
Aplagon has secured €7M to advance its clinical development strategy for APAC, a novel therapeutic targeting thrombo-inflammatory diseases. The funding will facilitate a Phase 2a clinical trial and completion of three ongoing trials.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Aplagon that raised within 45 days of this round, from Fundz verified event records.
- Lipella Pharmaceuticals raised $9K (Seed) on March 17, 2025.
- StimOxyGen raised $2M on March 11, 2025.
- HelloBetter raised $6.4M (Funding Round) on March 5, 2025.
- TRIMTECH Therapeutics raised $31M (Seed) on March 5, 2025.
- Whitehawk Therapeutics, Inc. raised $100M on March 4, 2025.
- Callio Therapeutics raised $187M (Series A) on March 3, 2025.
Who to call at Aplagon, and when
A new round usually means Aplagon is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aplagon raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aplagon, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aplagon. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aplagon raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aplagon raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.